Expanded mRNA Vaccine Production Reflected in CDMO Samsung Biologics’ Q3 Earnings Report
328 ViewsSamsung Biologics, one of the world’s largest contract development and manufacturing organizations (CDMOs), has released its earnings report for the third quarter of 2022. The report noted that Samsung….